Sign in

CIK 0001833141

  • Emerging growth company

Helus Pharma Inc.

Sign in to watch
Ticker
HELP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
British Columbia, Canada
Entity type
Other
Phone
+1 908-764-8385
Business address
100 KING STREET WEST, SUITE 5600, TORONTO, Ontario, Canada
Former names
CYBIN INC.
Open-market buys, last 90 days
$9,670,162
in 9 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$9,670,162. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-30 So Eric H. L. Director Grant or award +248,000 4,713,014
2026-09-30 Glavine Paul Chief Growth Officer Grant or award +248,000 4,750,191
2026-09-29 Cavers Greg Chief Financial Officer Purchase +3,000 $12.91 $39K 3,000
2026-09-21 Halstead Michael Chief Executive Officer Purchase +100,000 $13.47 $1.3M 168,568
2026-09-08 Glavine Paul Chief Growth Officer Purchase +100,000 $12.47 $1.2M 4,271,252
2026-09-08 Glavine Paul Chief Growth Officer Purchase +100,000 $12.47 $1.2M 4,271,252
2026-09-08 So Eric H. L. Executive Chair Purchase +100,000 $12.39 $1.2M 4,465,014
2026-09-04 So Eric H. L. Executive Chair Purchase +100,000 $12.09 $1.2M 4,365,014
2026-09-03 Glavine Paul Chief Growth Officer Purchase +100,000 $11.78 $1.2M 4,171,252
2026-09-01 So Eric H. L. Executive Chair Purchase +95,000 $11.81 $1.1M 4,265,014
2026-08-31 Glavine Paul Chief Growth Officer Purchase +90,000 $11.59 $1.0M 4,071,252

Page 1 of 1 · 11 trades